Lead sponsor
Spinogenix
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
1
Ongoing
36
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Trials by status
Active, not recruiting
1
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)mild-to-moderate ADPh 2Active, not recruiting24